Tim McCarthy | LifeSci Advisors |
Sergio Traversa | CEO |
Maged Shenouda | CFO |
Cedric O'Gorman | Chief Medical Officer |
Uy Ear | Mizuho Health |
Guofang Li | SVB Securities |
Andrea Tan | Goldman Sachs |
Andrew Tsai | Jefferies |
Jay Olson | Oppenheimer |
Greetings and welcome to Relmada Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Mr. Tim McCarthy. Thank you, you may begin.